BioAge Labs
BIOA
114 hedge funds and large institutions have $314M invested in BioAge Labs in 2025 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 23 reducing their positions, and 9 closing their positions.
4,182% more call options, than puts
Call options by funds: $728K | Put options by funds: $17K
222% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 9
151% more capital invested
Capital invested by funds: $125M → $314M (+$189M)
78% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 23
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
21% more funds holding
Funds holding: 94 → 114 (+20)
6.69% more ownership
Funds ownership: 59.3% → 66% (+6.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OCA
Octagon Capital Advisors
New York
|
+$14.2M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.31M |
| 3 |
Janus Henderson Group
London,
|
+$3.63M |
| 4 |
DP
Diadema Partners
Morristown,
New Jersey
|
+$2.4M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$15.5M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$9.41M |
| 3 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$2.25M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.1M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.27M |
BIOA Hedge Fund Activity: Q4 2025 in Review
114 of the 8,270 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q4 2025, worth a combined $314M — up 151% from $125M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new BIOA positions and 9 closed out — a net gain of 20 holders — while 41 added to existing stakes and 23 trimmed.
The largest buyer was Octagon Capital Advisors, opening a new position worth an estimated $14.2M. The largest seller was ADAR1 Capital Management, cutting an estimated $15.5M.
- 114 institutional investors held BioAge Labs (BIOA) as of Q4 2025, up from 94 in Q3 2025.
- Funds reported $314M of BioAge Labs stock for Q4 2025, up 151% quarter-over-quarter.
- 29 funds opened new BioAge Labs positions in Q4 2025 and 9 closed out, a net change of +20 holders.
- The largest BioAge Labs buyer in Q4 2025 was Octagon Capital Advisors, an estimated $14.2M added.
- The largest BioAge Labs seller in Q4 2025 was ADAR1 Capital Management, an estimated $15.5M sold.
Based on aggregated 13F filings for Q4 2025.